Clinical outcomes in patients with hepatitis D, cirrhosis and persistent hepatitis B virus replication, and receiving long-term tenofovir or entecavir

Interferon Treatment Duration in Patients With Chronic Delta Hepatitis and its Effect on the Natural Course of the Disease

(2018) Cihan Yurdaydin et al.   JOURNAL OF INFECTIOUS DISEASES

Molecular Signature and Mechanisms of Hepatitis D Virus-Associated Hepatocellular Carcinoma

(2018) Giacomo Diaz et al.   MOLECULAR CANCER RESEARCH

Targeting Hepatitis D

(2018) Mario Rizzetto   SEMINARS IN LIVER DISEASE

The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B

(2017) George V. Papatheodoridis et al.   HEPATOLOGY

Hepatitis delta-associated mortality in HIV/HBV-coinfected patients

(2017) Charles Béguelin et al.   JOURNAL OF HEPATOLOGY

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

(2017) Pietro Lampertico et al.   JOURNAL OF HEPATOLOGY

Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN)

(2017) Anika Wranke et al.   LIVER INTERNATIONAL

Antiviral treatment and liver-related complications in hepatitis delta

(2016) Anika Wranke et al.   HEPATOLOGY

The hepatitis delta virus: Replication and pathogenesis

(2016) Camille Sureau et al.   JOURNAL OF HEPATOLOGY

EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma

(2015) et al.   JOURNAL OF HEPATOLOGY

Hepatitis Delta Is a Major Determinant of Liver Decompensation Events and Death in HIV-Infected Patients

(2014) J. V. Fernandez-Montero et al.   CLINICAL INFECTIOUS DISEASES

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

(2014) Benjamin Heidrich et al.   HEPATOLOGY

O4 PROLONGED THERAPY OF HEPATITIS DELTA FOR 96 WEEKS WITH PEGYLATED-INTERFERON-α-2a PLUS TENOFOVIR OR PLACEBO DOES NOT PREVENT HDVRNA RELAPSE AFTER TREATMENT: THE HIDIT-2 STUDY

(2014) H. Wedemeyer et al.   JOURNAL OF HEPATOLOGY

High Serum Levels of HDV RNA Are Predictors of Cirrhosis and Liver Cancer in Patients with Chronic Hepatitis Delta

(2014) Raffaella Romeo et al.   PLoS One

Hepatitis delta virus induces specific DNA methylation processes in Huh-7 liver cancer cells

(2013) Giorgia Benegiamo et al.   FEBS LETTERS

Prevalence and clinical course of hepatitis delta infection in Greece: A 13-year prospective study

(2013) Emanuel K. Manesis et al.   JOURNAL OF HEPATOLOGY

Meta-analysis: antiviral treatment for hepatitis D

(2012) C. Triantos et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Entecavir Treatment of Chronic Hepatitis D

(2012) G. Kabacam et al.   CLINICAL INFECTIOUS DISEASES

Hepatitis delta virus

(2011) Sarah A Hughes et al.   LANCET

Peginterferon plus Adefovir versus Either Drug Alone for Hepatitis Delta

(2011) Heiner Wedemeyer et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D

(2010) Melanie Schaper et al.   JOURNAL OF HEPATOLOGY

Outcome of chronic delta hepatitis in Italy: A long-term cohort study

(2010) Grazia Anna Niro et al.   JOURNAL OF HEPATOLOGY

Replicative and Transcriptional Activities of Hepatitis B Virus in Patients Coinfected with Hepatitis B and Hepatitis Delta Viruses

(2010) T. Pollicino et al.   JOURNAL OF VIROLOGY

A 28-Year Study of the Course of Hepatitis Δ Infection: A Risk Factor for Cirrhosis and Hepatocellular Carcinoma

(2009) Raffaella Romeo et al.   GASTROENTEROLOGY

Hepatitis D: Thirty years after

(2009) Mario Rizzetto   JOURNAL OF HEPATOLOGY

Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV

(2008) Joel Gozlan et al.   JOURNAL OF HEPATOLOGY